BOLT
$12.74
Bolt Biotherapeutics
BOLT
Earnings Whisper ®
N/A
3rd Quarter September 2021
Consensus:  ($0.63)
Revenue:  $1.50 Mil
Thursday
Nov 11
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BOLT reports earnings?
Beat
Meet
Miss

Where is BOLT's stock price going from here?
Up
Flat
Down
Stock chart of BOLT
Analysts
Summary of analysts' recommendations for BOLT
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Bolt Biotherapeutics Inc. is a clinical-stage immuno-oncology company. It engages in the discovery, development, and commercialization of pharmaceutical products. The company's principal product includes BDC-1001. Bolt Biotherapeutics Inc. is based in Redwood city, California.